Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-653-9 | CAS number: 98-29-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- End of the study: 02/04/1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- other: Acute Oral Toxicity
- Limit test:
- no
Test material
- Reference substance name:
- 4-tert-butylpyrocatechol
- EC Number:
- 202-653-9
- EC Name:
- 4-tert-butylpyrocatechol
- Cas Number:
- 98-29-3
- Molecular formula:
- C10H14O2
- IUPAC Name:
- 4-tert-butylbenzene-1,2-diol
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Iffa Credo, 69210 L'Arbresle. France.
- Age at study initiation: 6 weeks old
- Weight at study initiation: 185 +/- 7g for the males, 149 +/- 7 g for the females
- Fasting period before study: 18 hours, they were then given food 4 hours after treatment.
- Housing: The animals were housed in groups of 4 to 7 animals of the same sex in polycarbonate cages (48x27x20 cm) during the acclimatization period and groups of 5 animals of the same sex during the study.
- Food consumption (e.g. ad libitum): ad libitum
- Water consumption (e.g. ad libitum): ad libitum
- Acclimation period: 5 days during which they were observed daily.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 50 +/- 20% relative humidity
- Air changes (per hr): the air was non-recycled and filtered by absolute filters.
- Photoperiod (hrs dark / hrs light): 12hr/12hr
In-life dates: From 12/12/1991 to 13/02/1992
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: paraffin oil
- Details on oral exposure:
- VEHICLE
A different vehicle (water for injections) was used for the preliminary assay.
- Batch n°: 1336 for water for injections (preliminary assay) and batch n°: 6852 for paraffin oil (main assay)
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
- Doses:
- preliminary assay: 2000 mg/kg bw
main assay: 490, 680, 880, 1200 mg/kg bw (males) and 680, 880 mg/kg bw (females) - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- DETAILS ON STUDY DESIGN
- Duration of observation period following administration: 14 days
- Frequency of observations: the animals were observed frequently after administration of the test substance and at least once a day for clinical signs and at least twice a day for mortality.
- Frequency of weighing: Animals were weighed just before administration of the test substance and then on days 5, 8 and 15.
- Necropsy of survivors performed: yes on day 15
- Other examinations performed: macroscopic examination at necropsy (digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and any other organ with obvious abnormalities) - Statistics:
- no data
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 815 mg/kg bw
- 95% CL:
- 643 - 1 049
- Mortality:
- Mortality was observed within the 24 hours of administration of the test substance. No sex-related differences were noted.
At the dose level of 2000 mg/kg, all animals found dead.
The mortality in males was 0%, 20%, 60% and 100% at the dose levels of 490, 680, 880 and 1200 mg/kg respectively. The mortality in females was 0% and 60% at the dose levels of 680 and 880 mg/kg respectively. - Clinical signs:
- other: Following administration of the test substance, a severe decrease in spontaneous activity accompanied by piloerection and dypsnea were seen at all dose levels. Other clinical signs noted in a few animals were hypersalivation and coma. Clinical signs were
- Gross pathology:
- At necropsy of the animals found dead during the study, signs of ulceration of the stomach were observed at all dose levels. The macroscopic examination revealed no abnormalities in the animals sacrified at the end of the study.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- TBC 100% ECAILLES is considered as harmful if swallowed.
EU GHS Classification:
Acute oral toxicity Cat. 4 (H302) - Executive summary:
In an acute oral toxicity study (CIT study, 7674 TAR, 1992), groups of 6 weeks old fasted Sprague-Dawley rats (5/sex) were given a single oral dose of 4 -tert-butylpyrocatechol (100% Ecailles) in paraffin oil at doses of 490, 680, 880 and 1200 mg/kg bw for males and at doses of 680 and 880 mg/kg bw for females. Animals were observed for 14 days.
Oral LD50 Males = 815 mg/kg bw (95% C.I.: 643 - 1049 mg/kg)
4 -tert-butylpyrocatechol is harmful based on the LD50 in males.
The mortality in males was 0%, 20%, 60%, 100%, and 100% at the dose levels of 490, 680, 880, 1200 and 2000 mg/kg respectively. The mortality in the females was 0%, 60% and 100% at 680, 880 and 2000 mg/kg respectively. The necropsy of animals found dead showed signs of ulceration of the stomach at all dose levels. The macroscopic observation revealed no abnormalities in the animals sacrified at the end of the study. The observed decrease in body weight gain, sometimes resulting in body weight loss, in few surviving animals returned to normal after day 5. It can be stated that, according to the results, the LD50 in the females was similar to that of males.
This acute oral study is classified as acceptable. It does satisfy the guideline requirement for an acute oral study (OECD 401) in the rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.